Cell and gene therapies (CGT) represent some of the most advanced and promising areas in modern medicine, but their development is accompanied by unique scientific and regulatory challenges. At MED Institute, we provide tailored services to accelerate the development of cell and gene therapy products, including assistance with product characterization, pre-clinical study design, and regulatory strategy. Our expertise in IND-enabling studies, potency and purity assay development, and compliance with FDA and EMA guidelines ensures that your therapy meets rigorous quality and safety standards. We also support the preparation and submission of regulatory documents and facilitates interactions with agencies to help move your therapy efficiently from bench to bedside.
Fluorescence Quantification and Sub-cellular Localization
Cell Enumeration
Gene expression profiling
OUR COMMITMENT
We are committed to consistently performing services with high quality, that deliver exceptional results, and add value to the client’s business.
For client surveys sent in 2024, we received ratings of 4.98/5 points (13).